Skip to content
healthcare.dev

MONTELUKAST SODIUM

NDC 16571-100, MONTELUKAST SODIUM, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-100
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MONTELUKAST SODIUM10 mg/1

Pharmacologic classes

Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]

Package NDCNDC-11Package
16571-100-091657101000990 TABLET in 1 BOTTLE (16571-100-09)
16571-100-10165710100101000 TABLET in 1 BOTTLE (16571-100-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/75723c5a-3c9e-468a-bc65-57b4c755889a
  • NADAC price for package 16571010009

    GET /v1/drugs/nadac/16571010009
  • NADAC price for package 16571010010

    GET /v1/drugs/nadac/16571010010

Use it

Look up 16571-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.